|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar
|
|
2
|
Yu G, Chen X, Chen S, Ye W, Hou K and
Liang M: Arsenic trioxide reduces chemo-resistance to
5-fluorouracil and cisplatin in HBx-HepG2 cells via complex
mechanisms. Cancer Cell Int. 15:1162015. View Article : Google Scholar :
|
|
3
|
Bao J, Lu Y, Deng Y, Rong C, Liu Y, Huang
X, Song L, Li S and Qin X: Association between IL-18 polymorphisms,
serum levels, and HBV-related hepatocellular carcinoma in a Chinese
population: A retrospective case-control study. Cancer Cell Int.
15:722015. View Article : Google Scholar :
|
|
4
|
Luo Y, Zhang X, Tan Z, Wu P, Xiang X, Dang
Y and Chen G: Astrocyte elevated gene-1 as a novel
clinicopathological and prognostic biomarker for gastrointestinal
cancers: A meta-analysis with 2999 patients. PLoS One.
10:e01456592015. View Article : Google Scholar :
|
|
5
|
Yu MA, Liang P, Yu XL, Han ZY, Dong XJ,
Wang YU, Cheng C and Li X: Multiple courses of immunotherapy with
different immune cell types for patients with hepatocellular
carcinoma after microwave ablation. Exp Ther Med. 10:1460–1466.
2015. View Article : Google Scholar :
|
|
6
|
Luo X, Yang S, Zhou C, Pan F, Li Q and Ma
S: MicroRNA-328 enhances cellular motility through
posttranscriptional regulation of PTPRJ in human hepatocellular
carcinoma. Onco Targets Ther. 8:3159–3167. 2015.
|
|
7
|
Li T, Zhao S, Song B, Wei Z, Lu G, Zhou J
and Huo T: Effects of transforming growth factor β-1 infected human
bone marrow mesenchymal stem cells on high- and low-metastatic
potential hepatocellular carcinoma. Eur J Med Res. 20:562015.
View Article : Google Scholar :
|
|
8
|
Zhang JW, Li Y, Zeng XC, Zhang T, Fu BS,
Yi HM, Zhang Q and Jiang N: miR-630 overexpression in
hepatocellular carcinoma tissues is positively correlated with
alpha-fetoprotein. Med Sci Monit. 21:667–673. 2015. View Article : Google Scholar :
|
|
9
|
Hou YF, Wei YG, Li B, Yang JY, Wen TF, Xu
MQ, Yan LN and Wang WT: Upper abdominal shape as a risk factor of
extended operation time and severe postoperative complications in
HCC hepatectomy through subcostal incision. World J Surg Oncol.
13:2982015. View Article : Google Scholar :
|
|
10
|
Zhao Y, Fang Z, Luo J, Liu Q, Xu G, Pan H,
Wei W and Yan Z: Evaluation of extrahepatic collateral arteries in
hepatocellular carcinoma in three independent groups in a single
center. Exp Ther Med. 10:2366–2374. 2015. View Article : Google Scholar :
|
|
11
|
Wang L, Wang J, Zhang X, Li J, Wei X,
Cheng J, Ling Q, Xie H, Zhou L, Xu X and Zheng S: Diagnostic value
of preoperative needle biopsy for tumor grading assessment in
hepatocellular carcinoma. PLoS One. 10:e01442162015. View Article : Google Scholar :
|
|
12
|
Selitsky SR, Baran-Gale J, Honda M, Yamane
D, Masaki T, Fannin EE, Guerra B, Shirasaki T, Shimakami T, Kaneko
S, et al: Small tRNA-derived RNAs are increased and more abundant
than microRNAs in chronic hepatitis B and C. Sci Rep. 5:76752015.
View Article : Google Scholar :
|
|
13
|
Zuo D, Chen L, Liu X, Wang X, Xi Q, Luo Y,
Zhang N and Guo H: Combination of miR-125b and miR-27a enhances
sensitivity and specificity of AFP-based diagnosis of
hepatocellular carcinoma. Tumour Biol. 37:6539–6549. 2016.
View Article : Google Scholar
|
|
14
|
Jiang L, Cheng Q, Zhang BH and Zhang MZ:
Circulating microRNAs as biomarkers in hepatocellular carcinoma
screening: A validation set from China. Medicine (Baltimore).
94:e6032015. View Article : Google Scholar :
|
|
15
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar
|
|
16
|
Fornari F, Ferracin M, Trerè D, Milazzo M,
Marinelli S, Galassi M, Venerandi L, Pollutri D, Patrizi C, Borghi
A, et al: Circulating microRNAs, miR-939, miR-595, miR-519d and
miR-494, Identify Cirrhotic Patients with HCC. PLoS One.
10:e01414482015. View Article : Google Scholar :
|
|
17
|
He R, Yang L, Lin X, Chen X, Lin X, Wei F,
Liang X, Luo Y, Wu Y, Gan T, et al: miR-30a-5p suppresses cell
growth and enhances apoptosis of hepatocellular carcinoma cells via
targeting AEG-1. Int J Clin Exp Pathol. 8:15632–15641. 2015.
|
|
18
|
de Carvalho AC, Scapulatempo-Neto C, Maia
DC, Evangelista AF, Morini MA, Carvalho AL and Vettore AL: Erratum:
Accuracy of microRNAs as markers for the detection of neck lymph
node metastases in patients with head and neck squamous cell
carcinoma. BMC Med. 13:1552015. View Article : Google Scholar :
|
|
19
|
de Carvalho AC, Scapulatempo-Neto C, Maia
DC, Evangelista AF, Morini MA, Carvalho AL and Vettore AL: Accuracy
of microRNAs as markers for the detection of neck lymph node
metastases in patients with head and neck squamous cell carcinoma.
BMC Med. 13:1082015. View Article : Google Scholar :
|
|
20
|
Liu H, Li W, Chen C, Pei Y and Long X:
MiR-335 acts as a potential tumor suppressor miRNA via
downregulating ROCK1 expression in hepatocellular carcinoma. Tumour
Biol. 36:6313–6319. 2015. View Article : Google Scholar
|
|
21
|
Yin J, Hou P, Wu Z, Wang T and Nie Y:
Circulating miR-375 and miR-199a-3p as potential biomarkers for the
diagnosis of hepatocellular carcinoma. Tumour Biol. 36:4501–4507.
2015. View Article : Google Scholar
|
|
22
|
Liu Y, Ren F, Luo Y, Rong M, Chen G and
Dang Y: Down-Regulation of MiR-193a-3p Dictates Deterioration of
HCC: A Clinical Real-Time qRT-PCR Study. Med Sci Monit.
21:2352–2360. 2015. View Article : Google Scholar :
|
|
23
|
Zhang X, Tang W, Li R, He R, Gan T, Luo Y,
Chen G and Rong M: Downregulation of microRNA-132 indicates
progression in hepatocellular carcinoma. Exp Ther Med.
12:2095–2101. 2016. View Article : Google Scholar :
|
|
24
|
Motawi TK, Shaker OG, El-Maraghy SA and
Senousy MA: Serum MicroRNAs as potential biomarkers for early
diagnosis of hepatitis C Virus-related hepatocellular carcinoma in
egyptian patients. PLoS One. 10:e01377062015. View Article : Google Scholar :
|
|
25
|
Tu H, Wei G, Cai Q, Chen X, Sun Z, Cheng
C, Zhang L, Feng Y, Zhou H, Zhou B and Zeng T: MicroRNA-212
inhibits hepatocellular carcinoma cell proliferation and induces
apoptosis by targeting FOXA1. Onco Targets Ther. 8:2227–2235.
2015.
|
|
26
|
Zhang JG, Shi Y, Hong DF, Song M, Huang D,
Wang CY and Zhao G: miR-148b suppresses cell proliferation and
invasion in hepatocellular carcinoma by targeting WNT1/β-catenin
pathway. Sci Rep. 5:80872015. View Article : Google Scholar :
|
|
27
|
Guo GX, Li QY, Ma WL, Shi ZH and Ren XQ:
MicroRNA-485-5p suppresses cell proliferation and invasion in
hepatocellular carcinoma by targeting stanniocalcin 2. Int J Clin
Exp Pathol. 8:12292–12299. 2015.
|
|
28
|
Liu Y, Ren F, Rong M, Luo Y, Dang Y and
Chen G: Association between underexpression of microrna-203 and
clinicopathological significance in hepatocellular carcinoma
tissues. Cancer Cell Int. 15:622015. View Article : Google Scholar :
|
|
29
|
Yao H, Liu X, Chen S, Xia W and Chen X:
Decreased expression of serum miR-424 correlates with poor
prognosis of patients with hepatocellular carcinoma. Int J Clin Exp
Pathol. 8:14830–14835. 2015.
|
|
30
|
Huang CS, Yu W, Cui H, Wang YJ, Zhang L,
Han F and Huang T: Increased expression of miR-21 predicts poor
prognosis in patients with hepatocellular carcinoma. Int J Clin Exp
Pathol. 8:7234–7238. 2015.
|
|
31
|
Chen Z, Huang Z, Ye Q, Ming Y, Zhang S,
Zhao Y, Liu L, Wang Q and Cheng K: Prognostic significance and
anti-proliferation effect of microRNA-365 in hepatocellular
carcinoma. Int J Clin Exp Pathol. 8:1705–1711. 2015.
|
|
32
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar
|
|
33
|
Koutsoulidou A, Mastroyiannopoulos NP,
Furling D, Uney JB and Phylactou LA: Expression of miR-1, miR-133a,
miR-133b and miR-206 increases during development of human skeletal
muscle. BMC Dev Biol. 11:342011. View Article : Google Scholar :
|
|
34
|
Babiarz JE, Ravon M, Sridhar S, Ravindran
P, Swanson B, Bitter H, Weiser T, Chiao E, Certa U and Kolaja KL:
Determination of the human cardiomyocyte mRNA and miRNA
differentiation network by fine-scale profiling. Stem Cells Dev.
21:1956–1965. 2012. View Article : Google Scholar
|
|
35
|
Li Y, Cai X, Guan Y, Wang L, Wang S, Li Y,
Fu Y, Gao X and Su G: Adiponectin upregulates miR-133a in cardiac
hypertrophy through AMPK activation and reduced ERK1/2
phosphorylation. PLoS One. 11:e01484822016. View Article : Google Scholar :
|
|
36
|
Wang LK, Hsiao TH, Hong TM, Chen HY, Kao
SH, Wang WL, Yu SL, Lin CW and Yang PC: MicroRNA-133a suppresses
multiple oncogenic membrane receptors and cell invasion in
non-small cell lung carcinoma. PLoS One. 9:e967652014. View Article : Google Scholar :
|
|
37
|
Guo J, Xia B, Meng F and Lou G: miR-133a
suppresses ovarian cancer cell proliferation by directly targeting
insulin-like growth factor 1 receptor. Tumour Biol. 35:1557–1564.
2014. View Article : Google Scholar
|
|
38
|
Zhang W, Liu K, Liu S, Ji B, Wang Y and
Liu Y: MicroRNA-133a functions as a tumor suppressor by targeting
IGF-1R in hepatocellular carcinoma. Tumour Biol. 36:9779–9788.
2015. View Article : Google Scholar
|
|
39
|
Yoshino H, Chiyomaru T, Enokida H,
Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N and Nakagawa
M: The tumour-suppressive function of miR-1 and miR-133a targeting
TAGLN2 in bladder cancer. Br J Cancer. 104:808–818. 2011.
View Article : Google Scholar :
|
|
40
|
Cui W, Zhang S, Shan C, Zhou L and Zhou Z:
microRNA-133a regulates the cell cycle and proliferation of breast
cancer cells by targeting epidermal growth factor receptor through
the EGFR/Akt signaling pathway. FEBS J. 280:3962–3974. 2013.
View Article : Google Scholar
|
|
41
|
Kojima S, Chiyomaru T, Kawakami K, Yoshino
H, Enokida H, Nohata N, Fuse M, Ichikawa T, Naya Y, Nakagawa M and
Seki N: Tumour suppressors miR-1 and miR-133a target the oncogenic
function of purine nucleoside phosphorylase (PNP) in prostate
cancer. Br J Cancer. 106:405–413. 2012. View Article : Google Scholar
|
|
42
|
Cheng H, Fertig EJ, Ozawa H, Hatakeyama H,
Howard JD, Perez J, Considine M, Thakar M, Ranaweera R, Krigsfeld G
and Chung CH: Decreased SMAD4 expression is associated with
induction of epithelial-to-mesenchymal transition and cetuximab
resistance in head and neck squamous cell carcinoma. Cancer Biol
Ther. 16:1252–1258. 2015. View Article : Google Scholar :
|
|
43
|
Guo Y, Sheng Q, Li J, Ye F, Samuels DC and
Shyr Y: Large scale comparison of gene expression levels by
microarrays and RNAseq using TCGA data. PLoS One. 8:e714622013.
View Article : Google Scholar :
|
|
44
|
Szklarczyk D, Franceschini A, Wyder S,
Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos
A, Tsafou KP, et al: STRING v10: Protein-protein interaction
networks, integrated over the tree of life. Nucleic Acids Res.
43:(Database issue). D447–D452. 2015. View Article : Google Scholar
|
|
45
|
Zhao L and Wang W: miR-125b suppresses the
proliferation of hepatocellular carcinoma cells by targeting
Sirtuin7. Int J Clin Exp Med. 8:18469–18475. 2015.
|
|
46
|
Chen Y, Dong X, Yu D and Wang X: Serum
miR-96 is a promising biomarker for hepatocellular carcinoma in
patients with chronic hepatitis B virus infection. Int J Clin Exp
Med. 8:18462–18468. 2015.
|
|
47
|
Gan TQ, Tang RX, He RQ, Dang YW, Xie Y and
Chen G: Upregulated MiR-1269 in hepatocellular carcinoma and its
clinical significance. Int J Clin Exp Med. 8:714–721. 2015.
|
|
48
|
Mao B and Wang G: MicroRNAs involved with
hepatocellular carcinoma (Review). Oncol Rep. 34:2811–2820. 2015.
View Article : Google Scholar
|
|
49
|
Yang W, Dou C, Wang Y, Jia Y, Li C, Zheng
X and Tu K: MicroRNA-92a contributes to tumor growth of human
hepatocellular carcinoma by targeting FBXW7. Oncol Rep.
34:2576–2584. 2015. View Article : Google Scholar
|
|
50
|
Yang J, Liu X, Yuan X and Wang Z: miR-99b
promotes metastasis of hepatocellular carcinoma through inhibition
of claudin 11 expression and may serve as a prognostic marker.
Oncol Rep. 34:1415–1423. 2015. View Article : Google Scholar
|
|
51
|
Jin Q, Li XJ and Cao PG: MicroRNA-26b
enhances the radiosensitivity of hepatocellular carcinoma cells by
targeting EphA2. Tohoku J Exp Med. 238:143–151. 2016. View Article : Google Scholar
|
|
52
|
Yang F, Li QJ, Gong ZB, Zhou L, You N,
Wang S, Li XL, Li JJ, An JZ, Wang DS, et al: MicroRNA-34a targets
Bcl-2 and sensitizes human hepatocellular carcinoma cells to
sorafenib treatment. Technol Cancer Res Treat. 13:77–86. 2014.
View Article : Google Scholar
|
|
53
|
Wu G, Wang Y, Lu X, He H, Liu H, Meng X,
Xia S, Zheng K and Liu B: Low mir-372 expression correlates with
poor prognosis and tumor metastasis in hepatocellular carcinoma.
BMC Cancer. 15:1822015. View Article : Google Scholar :
|
|
54
|
Drakaki A, Hatziapostolou M, Polytarchou
C, Vorvis C, Poultsides GA, Souglakos J, Georgoulias V and
Iliopoulos D: Functional microRNA high throughput screening reveals
miR-9 as a central regulator of liver oncogenesis by affecting the
PPARA-CDH1 pathway. BMC Cancer. 15:5422015. View Article : Google Scholar :
|
|
55
|
Wang W, Wang X, Zhang Y, Wang D, Gao H,
Wang L and Gao S: Prognostic role of microRNA-150 in various
carcinomas: a meta-analysis. Onco Targets Ther. 9:1371–1379. 2016.
View Article : Google Scholar :
|
|
56
|
Mirghasemi A, Taheriazam A, Karbasy SH,
Torkaman A, Shakeri M, Yahaghi E and Mokarizadeh A: Down-regulation
of miR-133a and miR-539 are associated with unfavorable prognosis
in patients suffering from osteosarcoma. Cancer Cell Int.
15:862015. View Article : Google Scholar :
|
|
57
|
Fujiwara T, Katsuda T, Hagiwara K, Kosaka
N, Yoshioka Y, Takahashi RU, Takeshita F, Kubota D, Kondo T,
Ichikawa H, et al: Clinical relevance and therapeutic significance
of microRNA-133a expression profiles and functions in malignant
osteosarcoma-initiating cells. Stem Cells. 32:959–973. 2014.
View Article : Google Scholar
|
|
58
|
Ji F, Zhang H, Wang Y, Li M, Xu W, Kang Y,
Wang Z, Wang Z, Cheng P, Tong D, et al: MicroRNA-133a,
downregulated in osteosarcoma, suppresses proliferation and
promotes apoptosis by targeting Bcl-xL and Mcl-1. Bone. 56:220–226.
2013. View Article : Google Scholar
|
|
59
|
Lan D, Zhang X, He R, Tang R, Li P, He Q
and Chen G: miR-133a is downregulated in non-small cell lung
cancer: A study of clinical significance. Eur J Med Res. 20:502015.
View Article : Google Scholar :
|
|
60
|
Akanuma N, Hoshino I, Akutsu Y, Murakami
K, Isozaki Y, Maruyama T, Yusup G, Qin W, Toyozumi T, Takahashi M,
et al: MicroRNA-133a regulates the mRNAs of two invadopodia-related
proteins, FSCN1 and MMP14, in esophageal cancer. Br J Cancer.
110:189–198. 2014. View Article : Google Scholar
|
|
61
|
Wang G, Zhu S, Gu Y, Chen Q, Liu X and Fu
H: MicroRNA-145 and microRNA-133a inhibited proliferation,
migration, and invasion, while promoted apoptosis in hepatocellular
carcinoma cells via targeting FSCN1. Dig Dis Sci. 60:3044–3052.
2015. View Article : Google Scholar
|
|
62
|
Lin XJ, Chong Y, Guo ZW, Xie C, Yang XJ,
Zhang Q, Li SP, Xiong Y, Yuan Y, Min J, et al: A serum microRNA
classifier for early detection of hepatocellular carcinoma: A
multicentre, retrospective, longitudinal biomarker identification
study with a nested case-control study. Lancet Oncol. 16:804–815.
2015. View Article : Google Scholar
|
|
63
|
Kaufmann R, Mussbach F, Henklein P and
Settmacher U: Proteinase-activated receptor 2-mediated calcium
signaling in hepatocellular carcinoma cells. J Cancer Res Clin
Oncol. 137:965–973. 2011. View Article : Google Scholar
|
|
64
|
Wu R, Duan L, Cui F, Cao J, Xiang Y, Tang
Y and Zhou L: S100A9 promotes human hepatocellular carcinoma cell
growth and invasion through RAGE-mediated ERK1/2 and p38 MAPK
pathways. Exp Cell Res. 334:228–238. 2015. View Article : Google Scholar
|
|
65
|
Huang WT, Wang HL, Yang H, Ren FH, Luo YH,
Huang CQ, Liang YY, Liang HW, Chen G and Dang YW: Lower expressed
miR-198 and its potential targets in hepatocellular carcinoma: A
clinicopathological and in silico study. Onco Targets Ther.
9:5163–5180. 2016. View Article : Google Scholar :
|
